Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer
XL Su, JW Wang, H Che, CF Wang, H Jiang… - Chinese Medical …, 2020 - mednexus.org
Lung cancer is a malignant tumor characterized by a rapid proliferation rate, less
survivability, high mortality, and metastatic potential. This review focuses on updated …
survivability, high mortality, and metastatic potential. This review focuses on updated …
FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
C Sun, W Gao, J Liu, H Cheng, J Hao - Respiratory research, 2020 - Springer
Background This study investigated the role of fibrinogen-like protein 1 (FGL1) in regulating
gefitinib resistance of PC9/GR non-small cell lung cancer (NSCLC). Methods The effect of …
gefitinib resistance of PC9/GR non-small cell lung cancer (NSCLC). Methods The effect of …
GPX4 plays a crucial role in Fuzheng Kang'ai decoction-induced non-small cell lung cancer cell ferroptosis
YY Zhao, YQ Yang, HH Sheng, Q Tang… - Frontiers in …, 2022 - frontiersin.org
Background: Fuzheng Kang'ai decoction (FZKA) has been widely used to treat Non-Small
Cell Lung Cancer (NSCLC) patients in China for decades, showing definitively curative …
Cell Lung Cancer (NSCLC) patients in China for decades, showing definitively curative …
Synthesis and characterisation of chitosan-encapsulated genistein: its anti-proliferative and anti-angiogenic activities
F Rahmani, E Karimi, E Oskoueian - Journal of microencapsulation, 2020 - Taylor & Francis
Aims: The study was carried out to synthesise and characterise the chitosan-encapsulated
genistein (CHI-En/Gen) and determine its anti-cancer and anti-angiogenic properties …
genistein (CHI-En/Gen) and determine its anti-cancer and anti-angiogenic properties …
[HTML][HTML] Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway
Q Tang, X Wang, Q Zhou, Q Li, X Yang, M Xu, R Wang… - Phytomedicine, 2023 - Elsevier
Background Current treatments for lung cancer have their own deficiencies, such as severe
adverse effect. Therefore, more safe and effective drugs are needed. Purpose Fuzheng …
adverse effect. Therefore, more safe and effective drugs are needed. Purpose Fuzheng …
Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients
Y Tang, Y Yang, J Luo, S Liu, Y Zhan… - Cancer …, 2021 - content.iospress.com
BACKGROUND: HSP60 and its partner HSP10 are members of heat shock proteins (HSPs)
family, which help mitochondrial protein to fold correctly. Mcl-1, a member of the Bcl-2 family …
family, which help mitochondrial protein to fold correctly. Mcl-1, a member of the Bcl-2 family …
Mechanism of action of Xiaoyao San in treatment of ischemic stroke is related to anti-apoptosis and activation of PI3K/Akt pathway
Y Xu, W Chen, Z Chen, M Huang, F Yang… - Drug Design …, 2021 - Taylor & Francis
Objective The traditional Chinese medicine (TCM) formulation Xiaoyao San (XYS) has a
good clinical effect in treating ischemic stroke (IS). We explored the mechanism and material …
good clinical effect in treating ischemic stroke (IS). We explored the mechanism and material …
Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p
S Li, Q Zhang, W Liu, C Zhao - BMC cancer, 2021 - Springer
Background Abnormal expression of long non-coding RNA (lncRNA) FTX (five prime to Xist),
which is involved in X chromosome inactivation, has been reported in various tumors …
which is involved in X chromosome inactivation, has been reported in various tumors …
Berbamine Inhibits Cell Proliferation and Migration and Induces Cell Death of Lung Cancer Cells via Regulating c‐Maf, PI3K/Akt, and MDM2‐P53 Pathways
L Liu, Z Xu, B Yu, L Tao, Y Cao - … ‐Based Complementary and …, 2021 - Wiley Online Library
Berbamine (BBM) is a natural product isolated from Berberis amurensis Rupr. We
investigated the influence of BBM on the cell viability, proliferation, and migration of lung …
investigated the influence of BBM on the cell viability, proliferation, and migration of lung …
The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a protocol for systematic review of randomized controlled trials
W Li, J Guo, Q Wang, J Tang, F You - Medicine, 2020 - journals.lww.com
Background: Colorectal cancer (CRC) is a public health problem and the world's leading
cancer killer. It is a disease with high incidence and mortality. Although chemotherapy has …
cancer killer. It is a disease with high incidence and mortality. Although chemotherapy has …